At the time of writing, GeneDx Holdings Corp [WGS] stock is trading at $129.6, down -0.85%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The WGS shares have gain 4.56% over the last week, with a monthly amount glided 7.74%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GeneDx Holdings Corp [NASDAQ: WGS] stock has seen the most recent analyst activity on July 09, 2025, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $110. Previously, Guggenheim started tracking the stock with Buy rating on May 15, 2025, and set its price target to $88. On May 09, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $80 on the stock. Wells Fargo started tracking the stock assigning a Equal Weight rating and suggested a price target of $34 on August 28, 2024. Craig Hallum initiated its recommendation with a Buy and recommended $43 as its price target on July 10, 2024.
For the past year, the stock price of GeneDx Holdings Corp fluctuated between $35.88 and $136.00. Currently, Wall Street analysts expect the stock to reach $120 within the next 12 months. GeneDx Holdings Corp [NASDAQ: WGS] shares were valued at $129.6 at the most recent close of the market. An investor can expect a potential drop of -7.41% based on the average WGS price forecast.
Analyzing the WGS fundamentals
According to GeneDx Holdings Corp [NASDAQ:WGS], the company’s sales were 362.32M for trailing twelve months, which represents an 45.63% jump. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.0%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.01 and Total Capital is 0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.23.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that GeneDx Holdings Corp [NASDAQ:WGS] has a current ratio of 2.87. In addition, the Quick Ratio stands at 2.70 and the Cash Ratio stands at 1.04. Considering the valuation of this stock, the price to sales ratio is 10.28, the price to book ratio is 13.43 and price to earnings (TTM) ratio is 6930.75.
Transactions by insiders
Recent insider trading involved Feeley Kevin, CHIEF FINANCIAL OFFICER, that happened on Sep 16 ’25 when 3728.0 shares were sold. CHIEF EXECUTIVE OFFICER, Stueland Katherine completed a deal on Sep 16 ’25 to sell 10501.0 shares. Meanwhile, Chief Executive Officer Stueland Katherine sold 3657.0 shares on Sep 09 ’25.
